Copied to clipboard!

Analysis of Somatic Mutations from Liquid Biopsy-Derived cfDNA in Advanced Cancers

This study aims to identify somatic mutations and characterize potential neoantigens for immunotherapeutic targeting using paired whole-exome sequencing (WES) of germline DNA and plasma-derived circulating cell-free DNA (cfDNA) from patients with advanced-stage cancers.

Type: Exome Sequencing
Archive: European Genome-phenome Archive (EGA)

1 Dataset

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID	Description	Technology	Samples
EGAD50000001671	This study involves paired whole-exome sequencing (WES) of germline DNA and plasma-derived circulating cell-free DNA (cfDNA) from patients with advanced-stage cancers, aiming to identify somatic mutations and characterize potential neoantigens for immunotherapeutic targeting.	Illumina HiSeq 4000	138